{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:06:20Z","timestamp":1792073180529,"version":"4.4.0"},"reference-count":37,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,8,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cerebral adrenoleukodystrophy (cALD) remains a devastating neurodegenerative disease; only allogeneic hematopoietic cell transplantation (HCT) has been shown to provide long-term disease stabilization and survival. Sixty boys undergoing HCT for cALD from 2000 to 2009 were analyzed. The median age at HCT was 8.7 years; conditioning regimens and allograft sources varied. At HCT, 50% demonstrated a Loes radiographic severity score \u2265 10, and 62% showed clinical evidence of neurologic dysfunction. A total of 78% (n = 47) are alive at a median 3.7 years after HCT. The estimate of 5-year survival for boys with Loes score &lt; 10 at HCT was 89%, whereas that for boys with Loes score \u2265 10 was 60% (P = .03). The 5-year survival estimate for boys absent of clinical cerebral disease at HCT was 91%, whereas that for boys with neurologic dysfunction was 66% (P = .08). The cumulative incidence of transplantation-related mortality at day 100 was 8%. Post-transplantation progression of neurologic dysfunction depended significantly on the pre-HCT Loes score and clinical neurologic status. We describe the largest single-institution analysis of survival and neurologic function outcomes after HCT in cALD. These trials were registered at www.clinicaltrials.gov as #NCT00176904, #NCT00668564, and #NCT00383448.<\/jats:p>","DOI":"10.1182\/blood-2011-01-329235","type":"journal-article","created":{"date-parts":[[2011,5,18]],"date-time":"2011-05-18T00:02:33Z","timestamp":1305676953000},"page":"1971-1978","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":257,"title":["Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report"],"prefix":"10.1182","volume":"118","author":[{"given":"Weston P.","family":"Miller","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Blood and Marrow Transplant Program, University of Minnesota Medical School, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Rothman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Clinical Neuroscience, University of Minnesota Medical School, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Nascene","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, University of Minnesota Medical School, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Kivisto","sequence":"additional","affiliation":[{"name":"Blood and Marrow Transplant Program, University of Minnesota Medical School, Minneapolis, MN; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd E.","family":"DeFor","sequence":"additional","affiliation":[{"name":"Blood and Marrow Transplant Program, University of Minnesota Medical School, Minneapolis, MN; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Ziegler","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Clinical Neuroscience, University of Minnesota Medical School, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Eisengart","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Clinical Neuroscience, University of Minnesota Medical School, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Leiser","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Clinical Neuroscience, University of Minnesota Medical School, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Raymond","sequence":"additional","affiliation":[{"name":"Department of Neurogenetics, Kennedy Krieger Institute, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy C.","family":"Lund","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Blood and Marrow Transplant Program, University of Minnesota Medical School, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Tolar","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Blood and Marrow Transplant Program, University of Minnesota Medical School, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Orchard","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Blood and Marrow Transplant Program, University of Minnesota Medical School, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"4","key":"2019111807201235700_B1","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.101","article-title":"Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening.","volume":"49","author":"Bezman","year":"2001","journal-title":"Ann Neurol"},{"issue":"2","key":"2019111807201235700_B2","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1042\/bst0290250","article-title":"Peroxisomal fatty acid alpha- and beta-oxidation in humans: enzymology, peroxisomal metabolite transporters and peroxisomal diseases.","volume":"29","author":"Wanders","year":"2001","journal-title":"Biochem Soc Trans"},{"issue":"4","key":"2019111807201235700_B3","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1471-4159.1976.tb04462.x","article-title":"Fatty acid abnormality in adrenoleukodystrophy.","volume":"26","author":"Igarashi","year":"1976","journal-title":"J Neurochem"},{"issue":"1","key":"2019111807201235700_B4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/1531-8249(199901)45:1<100::AID-ART16>3.0.CO;2-U","article-title":"Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls.","volume":"45","author":"Moser","year":"1999","journal-title":"Ann Neurol"},{"issue":"12","key":"2019111807201235700_B5","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.bbamcr.2006.07.010","article-title":"X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetic aspects.","volume":"1763","author":"Berger","year":"2006","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"2019111807201235700_B6","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/brain\/120.8.1485","article-title":"Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy.","volume":"120","author":"Moser","year":"1997","journal-title":"Brain"},{"key":"2019111807201235700_B7","unstructured":"Kennedy Krieger Institute, Baltimore, MD, USA and Academic Medical Center\/Emma Children's Hospital, Amsterdam, The Netherlands. X-linked adrenoleukodystrophy. Accessed January 15, 2011 http:\/\/www.x-ald.nl"},{"issue":"3","key":"2019111807201235700_B8","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1006\/bbrc.1994.2855","article-title":"X-linked adrenoleukodystrophy (ALD): a novel mutation of the ALD gene in 6 members of a family presenting with 5 different phenotypes.","volume":"205","author":"Berger","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"2019111807201235700_B9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00019052-200406000-00005","article-title":"Progress in X-linked adrenoleukodystrophy.","volume":"17","author":"Moser","year":"2004","journal-title":"Curr Opin Neurol"},{"key":"2019111807201235700_B10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1399-3046.2005.00447.x","article-title":"X-linked adrenoleukodystrophy: therapeutic approaches to distinct phenotypes.","volume":"9","author":"Mahmood","year":"2005","journal-title":"Pediatr Transplant"},{"issue":"3","key":"2019111807201235700_B11","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1148\/rg.253045118","article-title":"Childhood X-linked adrenoleukodystrophy: clinical-pathologic overview and MR imaging manifestations at initial evaluation and follow-up.","volume":"25","author":"Kim","year":"2005","journal-title":"Radiographics"},{"issue":"3","key":"2019111807201235700_B12","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1182\/blood-2003-10-3402","article-title":"Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999.","volume":"104","author":"Peters","year":"2004","journal-title":"Blood"},{"issue":"8","key":"2019111807201235700_B13","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1474-4422(07)70177-1","article-title":"Survival analysis of haematopoietic cell transplantation for childhood cerebral X-linked adrenoleukodystrophy: a comparison study.","volume":"6","author":"Mahmood","year":"2007","journal-title":"Lancet Neurol"},{"issue":"853","key":"2019111807201235700_B14","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1126\/science.162.3853.570","article-title":"Hurler and Hunter syndromes: mutual correction of the defect in cultured fibroblasts.","volume":"162","author":"Fratantoni","year":"1968","journal-title":"Science"},{"issue":"4","key":"2019111807201235700_B15","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1750-3639.2010.00390.x","article-title":"General aspects and neuropathology of X-linked adrenoleukodystrophy.","volume":"20","author":"Ferrer","year":"2010","journal-title":"Brain Pathol"},{"issue":"12","key":"2019111807201235700_B16","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/01.jnen.0000190064.28559.a4","article-title":"Adreno-leukodystrophy: oxidative stress of mice and men.","volume":"64","author":"Powers","year":"2005","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"2019111807201235700_B17","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/sj.bmt.1705571","article-title":"N-acetyl-L-cysteine improves outcome of advanced cerebral adrenoleukodystrophy.","volume":"39","author":"Tolar","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"5954","key":"2019111807201235700_B18","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1171242","article-title":"Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy.","volume":"326","author":"Cartier","year":"2009","journal-title":"Science"},{"issue":"26","key":"2019111807201235700_B19","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJM199006283222607","article-title":"Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation.","volume":"322","author":"Aubourg","year":"1990","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111807201235700_B20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.seminhematol.2009.10.006","article-title":"Transplant outcomes in leukodystrophies.","volume":"47","author":"Orchard","year":"2010","journal-title":"Semin Hematol"},{"issue":"1","key":"2019111807201235700_B21","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1399-3046.2008.00962.x","article-title":"Successful allogeneic unrelated bone marrow transplantation using reduced-intensity conditioning for the treatment of X-linked adrenoleukodystrophy in a one-yr-old boy.","volume":"13","author":"Okamura","year":"2009","journal-title":"Pediatr Transplant"},{"issue":"6","key":"2019111807201235700_B22","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.bbmt.2007.01.082","article-title":"Outcomes of unrelated umbilical cord blood transplantation for X-linked adrenoleukodystrophy.","volume":"13","author":"Beam","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"2019111807201235700_B23","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/01.tp.0000181457.43146.36","article-title":"Allogeneic hematopoietic stem cell transplantation for inherited disorders: experience in a single center.","volume":"81","author":"Ringd\u00e9n","year":"2006","journal-title":"Transplantation"},{"issue":"6","key":"2019111807201235700_B24","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1399-0012.2005.00411.x","article-title":"Treatment of X-linked childhood cerebral adrenoleukodystrophy by the use of an allogeneic stem cell transplantation with reduced intensity conditioning regimen.","volume":"19","author":"Resnick","year":"2005","journal-title":"Clin Transplant"},{"issue":"9231","key":"2019111807201235700_B25","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0140-6736(00)02629-5","article-title":"Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy.","volume":"356","author":"Shapiro","year":"2000","journal-title":"Lancet"},{"issue":"5","key":"2019111807201235700_B26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1023\/A:1005656029200","article-title":"Bone marrow transplantation for the treatment of X-linked adrenoleukodystrophy.","volume":"23","author":"Suzuki","year":"2000","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"2019111807201235700_B27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00043426-199805000-00013","article-title":"Matched unrelated human umbilical cord blood transplantation for X-linked adrenoleukodystrophy.","volume":"20","author":"Kapelushnik","year":"1998","journal-title":"J Pediatr Hematol Oncol"},{"issue":"5","key":"2019111807201235700_B28","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1651-2227.1997.tb08918.x","article-title":"Treatment of adrenoleukodystrophy with bone marrow transplantation.","volume":"86","author":"Malm","year":"1997","journal-title":"Acta Paediatr"},{"issue":"9","key":"2019111807201235700_B29","first-page":"1761","article-title":"Adrenoleukodystrophy: a scoring method for brain MR observations.","volume":"15","author":"Loes","year":"1994","journal-title":"AJNR Am J Neuroradiol"},{"key":"2019111807201235700_B30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/978-1-4419-9072-3_47","article-title":"Evaluation of the preventive effect of glyceryl trioleate-trierucate (\u201cLorenzo's oil\u201d) therapy in X-linked adrenoleukodystrophy: results of two concurrent trials.","volume":"544","author":"Moser","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"2019111807201235700_B31","volume-title":"Preschool and Primary Scale of Intelligence","author":"Wechsler","year":"2002","edition":"3rd ed"},{"key":"2019111807201235700_B32","volume-title":"Wechsler Intelligence Scale for Children","author":"Wechsler","year":"2003","edition":"4th ed"},{"key":"2019111807201235700_B33","volume-title":"Wechsler Abbreviated Scale of Intelligence","author":"Wechsler","year":"1999"},{"key":"2019111807201235700_B34","volume-title":"Wechsler Adult Intelligence Scale","author":"Wechsler","year":"1997","edition":"3rd ed"},{"key":"2019111807201235700_B35","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations.","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"2019111807201235700_B36","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables.","volume":"34","author":"Cox","year":"1972","journal-title":"J Royal Stat Soc B"},{"issue":"8","key":"2019111807201235700_B37","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/(SICI)1097-0258(19970430)16:8<901::AID-SIM543>3.0.CO;2-M","article-title":"Non-parametric inference for cumulative incidence functions in competing risks studies.","volume":"16","author":"Lin","year":"1997","journal-title":"Stat Med"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/7\/1971\/1348609\/zh803311001971.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/7\/1971\/1348609\/zh803311001971.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T11:23:07Z","timestamp":1741173787000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/118\/7\/1971\/29733\/Outcomes-after-allogeneic-hematopoietic-cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,18]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,8,18]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-01-329235","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,18]]}}}